Zummo Jacqueline 4

What Happened

• Jacqueline Zummo, Chief Scientific Operations Officer of Protara Therapeutics (TARA), had 3,724 shares withheld by the company to satisfy income tax obligations tied to the vesting of a previously granted Restricted Stock Unit (RSU) award. The withholding was reported at $6.67 per share, for a total value of $24,839. This was a tax-withholding event (transaction code F), not an open-market sale.

Key Details

• Transaction date: January 26, 2026; Filing date: January 27, 2026 (Form 4 accession 0001213900-26-008223).
• Shares withheld: 3,724 at $6.67 per share; total value reported: $24,839.
• Footnote: Withholding represents shares retained by the issuer to satisfy income tax obligations from the vesting of an RSU award granted on January 24, 2025 (see F1).
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Timeliness: Filed the day after the transaction, suggesting a timely Form 4 submission.

Context

• This was a routine tax-withholding related to RSU vesting (a common administrative action). It is not an open-market sale or a purchase and generally should not be interpreted as a directional signal about the insider’s view of the stock.